Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Journal of Interventional Cardiology|October 18, 2003
Mortality benefit of beta blockade in patients with acute coronary syndromes undergoing coronary intervention: pooled results from the Epic, Epilog, Epistent, Capture and Rapport TrialsKeith Ellis, James E Tcheng, Shelly Sapp, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|February 1, 2018
Ambulatory blood pressure in the dash diet trial: Effects of race and albuminuriaCrystal C Tyson, Huiman Barnhart, Shelly Sapp, et al.
The New England Journal of Medicine|November 17, 2006
Correction of anemia with epoetin alfa in chronic kidney diseaseAjay K Singh, Lynda Szczech, Kezhen L Tang, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 11, 2012
Impact of higher hemoglobin targets on blood pressure and clinical outcomes: a secondary analysis of CHOIRJula K Inrig, Shelly Sapp, Huiman Barnhart, et al.
Hematology (Amsterdam, Netherlands)|April 28, 2023
Biomarkers of erythropoiesis response to intravenous iron in a crossover pilot study in unexplained anemia of the elderlyJustin J Yoo, Harvey J Cohen, Andrew S Artz, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|April 28, 2012
Effect of hemoglobin target on progression of kidney disease: a secondary analysis of the CHOIR (Correction of Hemoglobin and Outcomes in Renal Insufficiency) trialJula K Inrig, Huiman X Barnhart, Donal Reddan, et al.
Kidney International|July 4, 2008
Secondary analysis of the CHOIR trial epoetin-alpha dose and achieved hemoglobin outcomesLynda A Szczech, Huiman X Barnhart, Jula K Inrig, et al.
Clinical Kidney Journal|August 2, 2016
Short-term effects of the DASH diet in adults with moderate chronic kidney disease: a pilot feeding studyCrystal C Tyson, Pao-Hwa Lin, Leonor Corsino, et al.
American Journal of Nephrology|June 6, 2013
Cardiovascular toxicity of epoetin-alfa in patients with chronic kidney diseasePeter A McCullough, Huiman X Barnhart, Jula K Inrig, et al.
The American Journal of Medicine|July 11, 2002
Multi-year follow-up of abciximab therapy in three randomized, placebo-controlled trials of percutaneous coronary revascularizationEric J Topol, A Michael Lincoff, Dean J Kereiakes, et al.
Pageof 2